TGFB1 and endometriosis: These data support the assumption that chronic inflammatory conditions, such as in endometriosis, correlated with increased levels of TGF-β, and related growth factors, could alter S1P metabolism and signaling, thus underlining a possible implication of the bioactive sphingolipid in the pathogenesis, as well as in the pathophysiology, of the disease.